Daniel J. Inglis,Tina C. Lavranos,Gabriel Kremmidiotis
申请号：
US14404782
公开号：
US20150133401A1
申请日:
2013.06.03
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention provides a method for treating a proliferative disease in a patient. The method comprises administering to a patient in need thereof: a) a vascular disrupting agent and (b) at least one hypoxia targeting agent. Preferred combinations are BNC105 and Pazopanib and BNC 105 and Bortezomib.
